251 related articles for article (PubMed ID: 24717638)
41. Effect of long-term medium to high-dose inhaled budesonide on bone mineral density in children with asthma: a cross-sectional study.
Patil SH; Kumar V; Nandan D
J Asthma; 2023 Dec; 60(12):2130-2136. PubMed ID: 37294051
[TBL] [Abstract][Full Text] [Related]
42. Corticosteroid use and bone mineral accretion in children with asthma: effect modification by vitamin D.
Tse SM; Kelly HW; Litonjua AA; Van Natta ML; Weiss ST; Tantisira KG;
J Allergy Clin Immunol; 2012 Jul; 130(1):53-60.e4. PubMed ID: 22608570
[TBL] [Abstract][Full Text] [Related]
43. Growth velocity in prepubertal children using both inhaled and intranasal corticosteroids.
Lasmar L; Brand PL; Lima AC; Maciel MF; Camargos P
Ann Allergy Asthma Immunol; 2016 Apr; 116(4):368-70. PubMed ID: 26896882
[No Abstract] [Full Text] [Related]
44. Inhaled corticosteroids in childhood asthma: growing concerns.
Witzmann KB; Fink RJ
Drugs; 2000; 59 Suppl 1():9-14; discussion 43-5. PubMed ID: 10741877
[TBL] [Abstract][Full Text] [Related]
45. Effect of inhaled corticosteroids on linear growth in children with persistent asthma.
Zhang L; Prietsch SO
Paediatr Respir Rev; 2014 Dec; 15(4):322-4. PubMed ID: 25164572
[No Abstract] [Full Text] [Related]
46. Inhaled corticosteroids and bone density.
Purucker M; Malozowski S
Lancet; 2000 Jul; 356(9227):427. PubMed ID: 10972393
[No Abstract] [Full Text] [Related]
47. The effects on growth of inhaled corticosteroids in children with persistent asthma.
Macedo MS
Am J Nurs; 2015 Jun; 115(6):21. PubMed ID: 26017995
[No Abstract] [Full Text] [Related]
48. Persistent growth effects of inhaled corticosteroids.
Ohn M; Jaffe A; Selvadurai H
J Paediatr Child Health; 2016 Oct; 52(10):964-966. PubMed ID: 27739208
[No Abstract] [Full Text] [Related]
49. Bone mineral density in prepubertal asthmatics receiving corticosteroid treatment.
Harris M; Hauser S; Nguyen TV; Kelly PJ; Rodda C; Morton J; Freezer N; Strauss BJ; Eisman JA; Walker JL
J Paediatr Child Health; 2001 Feb; 37(1):67-71. PubMed ID: 11168874
[TBL] [Abstract][Full Text] [Related]
50. Asthma, growth and inhaled corticosteroids.
Price JF
Respir Med; 1993 Feb; 87 Suppl A():23-6. PubMed ID: 8497711
[TBL] [Abstract][Full Text] [Related]
51. Update of growth effects of inhaled and intranasal corticosteroids.
Skoner D
Curr Opin Allergy Clin Immunol; 2002 Feb; 2(1):7-10. PubMed ID: 11964744
[TBL] [Abstract][Full Text] [Related]
52. Inhaled Corticosteroids and Endocrine Effects in Childhood.
Allen DB
Endocrinol Metab Clin North Am; 2020 Dec; 49(4):651-665. PubMed ID: 33153672
[TBL] [Abstract][Full Text] [Related]
53. Is enough attention being given to the adverse effects of corticosteroid therapy?
Hougardy DM; Peterson GM; Bleasel MD; Randall CT
J Clin Pharm Ther; 2000 Jun; 25(3):227-34. PubMed ID: 10886467
[TBL] [Abstract][Full Text] [Related]
54. Bone mineral density in normal and asthmatic children.
Kinberg KA; Hopp RJ; Biven RE; Gallagher JC
J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 1):490-7. PubMed ID: 8083454
[TBL] [Abstract][Full Text] [Related]
55. Genetic risk factors for decreased bone mineral accretion in children with asthma receiving multiple oral corticosteroid bursts.
Park HW; Ge B; Tse S; Grundberg E; Pastinen T; Kelly HW; Tantisira KG
J Allergy Clin Immunol; 2015 Nov; 136(5):1240-6.e1-8. PubMed ID: 26025128
[TBL] [Abstract][Full Text] [Related]
56. Inhaled corticosteroids and bone density.
Tait V; Lockwood F; Patel E; Chong T
Lancet; 2000 Jul; 356(9227):425-6; author reply 426-7. PubMed ID: 10972391
[No Abstract] [Full Text] [Related]
57. Inhaled corticosteroids: past lessons and future issues.
Allen DB; Bielory L; Derendorf H; Dluhy R; Colice GL; Szefler SJ
J Allergy Clin Immunol; 2003 Sep; 112(3 Suppl):S1-40. PubMed ID: 14515117
[TBL] [Abstract][Full Text] [Related]
58. Clinical adverse effects of inhaled corticosteroids: results of a questionnaire survey of asthma specialists.
Storms WW; Theen C
Ann Allergy Asthma Immunol; 1998 May; 80(5):391-4. PubMed ID: 9609608
[TBL] [Abstract][Full Text] [Related]
59. Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects.
Cave A; Arlett P; Lee E
Pharmacol Ther; 1999 Sep; 83(3):153-79. PubMed ID: 10576291
[TBL] [Abstract][Full Text] [Related]
60. Inhaled corticosteroids and bone density.
Donckier JE; Delgrange E; Boutsen Y
Lancet; 2000 Jul; 356(9227):425; author reply 426-7. PubMed ID: 10972390
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
